1
Back
Haematologica cover

Haematologica

IF7.9
Papers6399
Citations22342
Journal Papers 29727
Publication Date
WHEN TRIAL DESIGN MEETS APPROVED MAINTENANCE: A SINGLE-CENTER REAL-WORLD EXPERIENCE WITH DARA-VTD INDUCTION AND CONSOLIDATION FOLLOWED BY LENALIDOMIDE MAINTENANCE IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA
delete2026-04-01
delete0
PREAI
deleteBelotti, A.; Terlizzi, S.; Martorana, S.; Ribolla, R.; Crippa, C.; Ferrari, S.; Bianchetti, N.; Bottelli, C.; Cattaneo, C.; Chiarini, M.; Giustini, V.; Roccaro, A.; Tucci, A.
deleteShare
deleteSave
FROM BENCH TO BEDSIDE: DRUG SENSITIVITY PROFILING TO OPTIMIZE THERAPY IN RELAPSED MULTIPLE MYELOMA
delete2026-04-01
delete0
PREAI
deleteCassano, R. Cassano; Martins, T.; Coffey, D.; Buda, G.; Galimberti, S.; Melillo, L. M. A.; Donnelly, R.; Kwok, M.; Green, D.; Banerjee, R.; Cicero, K.; Gooley, T.; Silbermann, R.; Becker, P.; Cowan, A. J.; Dima, D.
deleteShare
deleteSave
MONOCLONAL AND POLYCLONAL CIRCULATING PLASMA CELLS ARE ASSOCIATED WITH DISEASE DISSEMINATION IN MULTIPLE MYELOMA
delete2026-04-01
delete0
PREAI
deleteVigliotta, I.; Varacalli, A.; Talarico, M.; Solli, V.; Taurisano, B.; Armuzzi, S.; Pistis, I.; Vuong, V. M.; Vitale, A.; Mazzocchetti, G.; Borsi, E.; Croce, A.; Martello, M.; Poletti, A.; Nanni, C.; Mancuso, K.; Puppi, M.; Cavo, M.; Zamagni, E.; Terragna, C.
deleteShare
deleteSave
RANDOMIZED COMPARISON OF ISATUXIMAB-RD INDUCTION FOLLOWED BY ISA R MAINTENANCE VS. RD INDUCTION FOLLOWED BY R MAINTENANCE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (AGMT MM04 TRIAL)
delete2026-04-01
delete0
PREAI
deleteLudwig, H.; Melchardt, T.; Terpos, E.; Bila, J.; Schreder, M.; Bernhard, S.; Podar, K.; Katodritou, E.; Sliwa, T.; Djurdjevic, P.; Delimpasi, S.; Leisch, M.; Mitrovic, M.; Gavriatopoulou, M.; Ntanasis-Stathopoulos, I.; Autzinger, E. M.; Zabernigg, A.; Fillitz, M.; Woll, E.; Pichler, P.; De Tejada, I. M. Saenz; Paiva, B.; Greil, R.
deleteShare
deleteSave
THE LONG TERM PROGNOSTIC IMPACT OF CHROMOSOME 1 ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
delete2026-04-01
delete0
PREAI
deleteIannozzi, N.; Sammarelli, G.; Todaro, G.; Poletti, A.; Scita, M.; Dalla Palma, B.; Bernardi, M.; Sitzia, C.; Giuliani, N.
deleteShare
deleteSave
MANAGEMENT OF NEUROLOGICAL TOXICITIES OF PATIENTS TREATED WITH IMMUNOTHERAPIES FOR MULTIPLE MYELOMA: A SINGLE-CENTER REAL WORLD EXPERIENCE
delete2026-04-01
delete0
PREAI
deleteManzato, E.; Puppi, M.; Talarico, M.; Iezza, M.; Masci, S.; Ghibellini, S.; Vitale, A.; Barbato, S.; Tacchetti, P.; Pantani, L.; Mancuso, K.; Zamagni, E.
deleteShare
deleteSave
DARATUMUMAB-BORTEZOMIB-MELPHALAN-PREDNISONE VS. DARATUMUMAB-LENALIDOMIDE-DEXAMETHASONE IN TRANSPLANT-INELIGIBLE REAL-LIFE PATIENTS WITH MULTIPLE MYELOMA: A SUBANALYSIS OF THE PHASE IV REAL MM TRIAL
delete2026-04-01
delete0
PREAI
deleteCani, L.; Bringhen, S.; Piciocchi, A.; Giuliani, N.; Mangiacavalli, S.; Falcone, A. P.; Benevolo, G.; Capriata, M.; Vassallo, F.; Ciceri, F.; Pane, F.; Floris, R.; Cantonetti, M.; Pezzatti, S.; D'Agostino, M.; Casson, A.; Evangelista, A.; Saraci, E.; Mirabile, M.; Gamberi, B.; Conconi, A.; Pietrantuono, G.; Galieni, P.; Curci, P.; Margiotta-Casaluci, G.; Liso, A.; Scaldaferri, M.; Bruno, B.; Boccadoro, M.; Larocca, A.
deleteShare
deleteSave
BIOPSY SPECIFIC CHARACTERISTICS ARE IMPORTANT IN DETECTING AMYLOID IN PATIENTS WITH AMYLOIDOSIS
delete2026-04-01
delete0
PREAI
deleteWeverling, F. G.; Vinkenborg, A.; Leguit, R. J.; Minnema, M. C.
deleteShare
deleteSave
PERIPHERAL MEASURABLE RESIDUAL DISEASE ACTIVITY ASSESSMENT BY MALDI-TOF MASS SPECTROMETRY IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA IN THE PHASE 3 GMMG-HD7 TRIAL
delete2026-04-01
delete0
PREAI
deleteJin, J. X.; Ginde, V. R.; Huhn, S.; Reichert, P. H.; Bertsch, U.; Fenk, R.; Besemer, B.; Boquoi, A.; Schroers, R.; Von Metzler, I.; Hanel, M.; Mann, Ch.; Leypoldt, L. B.; Heilmeier, B.; Scheid, C.; Peters-Regehr, T.; Blau, I. W.; Muller-Tidow, C.; Luntz, S.; Holderried, T. A. W.; Trautmann-Grill, K.; Gezer, D.; Klaiber-Hakimi, M.; Muller, M.; Shumilov, E.; Knauf, W.; Michel, C. S.; Geer, T.; Riesenberg, H.; Lutz, Ch.; Raab, M. S.; Weinhold, N.; Hoffmann, M.; Benner, A.; Findeisen, P.; Weisel, K. C.; Salwender, H. J.; Goldschmidt, H.; Mai, E. K.
deleteShare
deleteSave
Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm
delete2026-04-01
delete0
PREAI
deleteBarosi, Giovanni; Rosti, Vittorio; Campanelli, Rita; Massa, Margherita; Abba, Carlotta; Carolei, Adriana; Catarsi, Paolo; Inzoli, Alessandro; Pergola, Lorena; Barbui, Tiziano; Tatarelli, Caterina; Finazzi, Maria Chiara; Condorelli, Annalisa; Salmoiraghi, Silvia; Rambaldi, Alessandro; Gianatti, Andrea; De Stefano, Valerio; Galli, Anna; Gandossini, Martina; Bardelli, Michela; Gale, Robert Peter; Malcovati, Luca
deleteShare
deleteSave
DARA-VTD AND ASCT plus LENALIDOMIDE LED TO HIGH COMPLETE REIMISSION AND MINIMAL RESIDUAL DISEASE NEGATIVITY RATES BY NGF: A REAL-WORLD STUDY OF THE TUSCAN MYELOMA NETWORK IN 228 PATIENTS
delete2026-04-01
delete0
PREAI
deleteVenanzi, V.; Ciofini, S.; Antonioli, E.; Buda, G.; Bestoso, E.; Raspadori, D.; Candi, V.; Pengue, L.; Del Giudice, M. L.; Caremani, A.; Moretti, S.; Fontanelli, G.; Attucci, I.; Pirrotta, M. T.; Biagiotti, C.; Birtolo, S.; Grammatico, S.; Pilerci, S.; Notarfranchi, L.; Tancredi, G.; Galimberti, S.; Bocchia, M.; Gozzetti, A.
deleteShare
deleteSave
PROGNOSTIC IMPACT OF INTERPHASE FISH IN MULTIPLE MYELOMA: SINGLE-CENTER IRISH EXPERIENCE
delete2026-04-01
delete0
PREAI
deletePramod, T.; Bannaga, A.; Kumar, S.; Hennessy, B.; El Hassadi, E.
deleteShare
deleteSave
DARATUMUMAB MONOTHERAPY VERSUS ACTIVE MONITORING IN PATIENTS WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA: AQUILA OUTCOMES BASED ON MAYO 2018/IMWG 2020 RISK STRATIFICATION, IMWG 2020 PLUS CYTOGENETIC CRITERIA, AND AGE
delete2026-04-01
delete0
PREAI
deleteSchjesvold, F.; Voorhees, P. M.; Dimopoulos, M. A.; Cohen, Y. C.; Hungria, V.; Sandhu, I.; Lindsay, J.; Baker, R. I.; Suzuki, K.; Kosugi, H.; Levin, M. -D; Beksac, M.; Stockerl-Goldstein, K.; Magen, H.; Oriol, A.; Mikala, G.; Garate, G.; Theunissen, K.; Spicka, I.; Mylin, A. K.; Hallam, S.; Bringhen, S.; Uttervall, K.; Pula, B.; Khan, A. M.; Medvedova, E.; Ye, J. C.; Cowan, A. J.; Moreau, P. H.; Mateos, M-v.; Goldschmidt, H.; Vieyra, D.; Raval, A.; Sha, L.; Li, L.; Rousseau, E.; Dennis, R. M.; Carson, R. L.; Rajkumar, S. V.
deleteShare
deleteSave
Clinical and genomic features of macrofocal multiple myeloma: a distinct profile
delete2026-04-01
delete0
PREAI
deleteLiu, Jin; Fan, Jianling; Zhou, Xinyi; Chen, Xi; Hu, Xiaoli; He, Haiyan; Jin, Lina; Fu, Weijun; Hou, Jian; Du, Juan
deleteShare
deleteSave
BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE/DEXAMETHASONE IN NEWLY DIAGNOSED INTERMEDIATE-FIT AND FRAIL MULTIPLE MYELOMA: LONG-TERM EFFICACY AND SAFETY FROM THE PHASE 1/2 BELARD CLINICAL TRIAL
delete2026-04-01
delete0
PREAI
deleteTerpos, E.; Gavriatopoulou, M.; Stathopoulos, I. n.; Malandrakis, P.; Kanellias, N.; Migkou, M.; Theodorakakou, F.; Solia, E.; Papaiakovou, E. e.; Kastritis, E.; Dimopoulos, M. a.
deleteShare
deleteSave
BISPECIFIC ANTIBODIES IN FRAIL AND ELDERLY MULTIPLE MYELOMA PATIENTS WITH ECOG >1: REAL-WORLD IMPACT OF PERFORMANCE STATUS AND DOSE MODIFICATIONS ON OUTCOMES
delete2026-04-01
delete0
PREAI
deleteStoumbos, D.; Antoniou, A.; Lampropoulos, K.; Chrysoglou, S.; Prifti, C.; Panagiotouni, M.; Dadakaridou, M.; Giourgouli, S.; Stefanidis, K.; Kotsopoulou, M.
deleteShare
deleteSave